The DosePro system is designed for self-administration of a pre-filled, single dose of liquid drug, subcutaneously, without a needle.
DosePro needle-free system delivers larger dose viscous drug formulations with increased safety and convenience compared to needle-based injection.
Battelle Health and Life Sciences Global Business president Barbara Kunz said the collaboration enables Battelle to expand the company’s platform of drug delivery solutions to the pharmaceutical customers.
"We believe DosePro will be able to assist our clients with addressing many of the challenges they face today, in particular, the delivery of highly viscous drug formulations," Kunz added.